Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Danaher 3Q earnings beat but shares fall on disappointing outlook
12:44pm, Tuesday, 24'th Oct 2023
Danaher (NYSE:DHR)'s third quarter earnings topped Wall Street estimates on the top and bottom lines but its weak guidance saw investors retreat from the stock. The company - which designs, manufac
Hey, Warren! 3 Stocks Buffett Should Buy Now.
11:58am, Tuesday, 24'th Oct 2023
Everyone in the business media has a suggestion or two of what stocks Warren Buffett should buy or companies Berkshire Hathaway (NYSE: BRK-A , NYSE: BRK-B ) ought to acquire. I've written several arti
Danaher Corporation (DHR) Q3 2023 Earnings Call Transcript
10:35am, Tuesday, 24'th Oct 2023
Danaher Corporation (NYSE:DHR ) Q3 2023 Earnings Conference Call October 24, 2023 8:00 AM ET Company Participants John Bedford - Vice President of Investor Relations Rainer Blair - President and Chief
Danaher (DHR) Surpasses Q3 Earnings and Revenue Estimates
08:16am, Tuesday, 24'th Oct 2023
Danaher (DHR) came out with quarterly earnings of $2.02 per share, beating the Zacks Consensus Estimate of $1.83 per share. This compares to earnings of $2.56 per share a year ago.
Danaher Tops Earnings and Revenue Estimates. The Stock Is Rising.
07:56am, Tuesday, 24'th Oct 2023
Danaher posts third-quarter earnings of $2.02 a share on revenue of $6.87 billion.
7 Stocks to Buy Before They Become the Next Trillion-Dollar Companies: October Edition
12:25pm, Thursday, 19'th Oct 2023
The trillion-dollar valuation club is not an easy one to reach. In fact, a grand total of just nine companies have reached this figure to-date.
Will Diagnostic Unit Weakness Mar Danaher's (DHR) Q3 Earnings?
12:02pm, Monday, 16'th Oct 2023
Danaher's (DHR) Q3 results are likely to be hurt by weakness in the Biotechnology and Diagnostics segments due to a decrease in the sale of COVID-related products.
Exlusive: Why Abcam founder believes Danaher's acquisition offer falls short
08:46am, Monday, 16'th Oct 2023
In an exclusive interview with Thomas Warner (TW) of Proactive London, Dr Jonathan Milner (JM), the founder of life sciences company Abcam PLC (NASDAQ:ABCM), discusses why he believes the $24 per shar
IPOs are out of fashion. Here's what companies are doing instead.
11:39am, Friday, 06'th Oct 2023
While the current deal landscape on Wall Street remains low on M&A, initial public offerings (IPOs), and other transactions, corporate spinoffs are chugging along.
Veralto: Thoughts On The Danaher Spinoff
01:14pm, Monday, 02'nd Oct 2023
Veralto Corporation, the former Environmental & Applied Solutions segment of Danaher Corporation, has started trading as a publicly traded entity. Veralto is a $5 billion business focused on water and
Why Shares of Danaher Are Down Monday
12:21pm, Monday, 02'nd Oct 2023
Danaher's revenues declined in the second quarter. Its spinoff, Veralto, began trading on Monday.
Veralto stock to join S&P 500, Kohl's to join S&P SmallCap 600
05:43pm, Thursday, 28'th Sep 2023
Danaher Corp. DHR, -0.10% spinoff Veralto Corp. VLTO.WI, +5.02% will be added to the S&P 500 before trading Monday, when it replaces DXC Technology Co. DXC, +0.59%, which in turn will move to the S&P
Danaher Schedules Third Quarter 2023 Earnings Conference Call
04:15pm, Tuesday, 26'th Sep 2023
WASHINGTON, Sept. 26, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2023 on Tuesday, October 24, 202
Danaher Lowers Price Of Tuberculosis Test After Pressure Campaign
03:53pm, Tuesday, 19'th Sep 2023
Popular novelist and YouTuber John Green as well as international health nonprofits had been running a weeklong pressure campaign against the company.
The 7 Most Undervalued Safe Stocks to Buy in September 2023
09:47pm, Wednesday, 13'th Sep 2023
September — widely regarded as the “worst month for the stock market” — is living up to its reputation. In fact, the S&P 500 is down 1% since August, in line with its average 1.1% monthly decl
